Russell Investments »

Black Diamond Therapeutics shares owned by Russell Investments

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Russell Investments

Quarter filed Position value Share count Share price at filing
2025-09-30 $948 250 3.79
2025-06-30 $620 250 2.48
2020-12-31 $204k 6.4k 32.04
2020-09-30 $192k 6.4k 30.16

More positions owned by Russell Investments

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Meta Platforms Common Stock (META)
Alphabet Common Stock (GOOGL)
Alphabet Common Stock (GOOG)
Broadcom Common Stock (AVGO)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Mastercard Incorporated Common Stock (MA)
Tesla Common Stock (TSLA)
Welltower Common Stock (WELL)
J P Morgan Chase And Common Stock (JPM)
Visa Common Stock (V)
Oracle Corp Common Stock (ORCL)

View all positions for Russell Investments

Top funds holding Black Diamond Therapeutics

T. Rowe Price Investment Management
Vestal Point Capital
NEA Management Company
Vanguard Group
Tang Capital Management
Marshall Wace
Siren
BlackRock
Arrowstreet Capital, Limited Partnership
Millennium Management
UBS Group
AWM Investment Company
Renaissance Technologies
Geode Capital Management
Northern Trust

View all funds holding Black Diamond Therapeutics